Stress hormone GC is the natural agonist of GR in humans, and its increase during breast cancer progression leads to the activation of the receptor and increased expression of kinase ROR1 at distant metastatic sites, increases colonization, and reduces survival in mice models (41). Here, ROR1 is linked to breast carcinoma.